End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.9 SEK | -0.68% | +1.15% | +31.44% |
22/04 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
13/02 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
Chart calendar EQL Pharma AB
Upcoming events on EQL Pharma AB
Past events on EQL Pharma AB
13/02/2024 | Q3 2024 Earnings Release |
17/11/2023 | Q2 2024 Earnings Release |
11/05/2023 | Q4 2023 Earnings Release |
14/02/2023 | Q3 2023 Earnings Release |
11/11/2022 | Interim 2023 Earnings Release |
17/08/2022 | Annual General Meeting |
16/08/2022 | Q1 2023 Earnings Release |
13/05/2022 | FY 2022 Earnings Release |
16/02/2022 | Q3 2022 Earnings Release |
11/11/2021 | Interim 2022 Earnings Release |
17/08/2021 | Annual General Meeting |
16/08/2021 | Q1 2022 Earnings Release |
06/05/2021 | FY 2021 Earnings Release |
18/02/2021 | Q3 2021 Earnings Release |
Annual results
Fiscal Period | Marzo | 2023 | 2024 |
---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 | 363 |
EBITDA Million SEK | Released Forecast Spread | 0,00 | 94,7 |
EBIT Million SEK | Released Forecast Spread | 0,00 | 81,8 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 | 75,2 |
Net income Million SEK | Released Forecast Spread | 30,9 | 60,0 |
EPS SEK | Released Forecast Spread | 1,06 | 2,07 |
Announcement Date | 11/05/23 | - |
Quarterly results
Fiscal Period | Marzo | 2024 Q4 |
---|---|---|
EBITDA Million SEK | Released Forecast Spread | 17,0 |
EBIT Million SEK | Released Forecast Spread | 14,0 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 13,0 |
Net income Million SEK | Released Forecast Spread | 11,0 |
EPS SEK | Released Forecast Spread | 0,37 |
Announcement Date | - |
Past sector events for EQL Pharma AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EQL Stock
- Calendar EQL Pharma AB